„Checkpoints“
Suchergebnisse
349 Treffer
-
TIGIT axis: novel immune checkpoints in anti-leukemia immunity
-
Checkpoints controlling the induction of B cell mediated autoimmunity in human autoimmune diseases
-
Improving Cancer Immunotherapy with CRISPR‐Based Technology
-
Multistage Sensitive NanoCRISPR Enable Efficient Intracellular Disruption of Immune Checkpoints for Robust Innate and Adaptive Immune Coactivation
-
Immune checkpoints related-LncRNAs can identify different subtypes of lung cancer and predict immunotherapy and prognosis
-
Combined Application of Nanotechnology and Multiple Therapies with Tumor Immune Checkpoints
-
Blockade of novel immune checkpoints and new therapeutic combinations to boost antitumor immunity
-
Prognostic significance and therapeutic potentials of immune checkpoints in osteosarcoma
-
Monitoring checkpoints of metabolism and protein biogenesis in mitochondria by Phos-tag technology
-
Macrophage-Based Combination Therapies as a New Strategy for Cancer Immunotherapy
-
Metabolic remodeling maintains a reducing environment for rapid activation of the yeast DNA replication checkpoint
-
Inhibitory immune checkpoints PDCD-1 and LAG-3 hypermethylation may reduce the risk of colorectal cancer
-
Immunohistochemical analysis of glassy cell carcinoma of the cervix reveals robust lymphocyte infiltrate and the expression of targetable inhibitory immune checkpoints
-
Modulation of intrinsic inhibitory checkpoints using nano‐carriers to unleash NK cell activity
-
Inhibitors of immune checkpoints—PD-1, PD-L1, CTLA-4—new opportunities for cancer patients and a new challenge for internists and general practitioners
-
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
-
Correlation between the immune checkpoints and EMT genes proposes potential prognostic and therapeutic targets in ESCC
-
Potential Role of the Galectin-9/TIM-3 Axis in the Disparate Progression of SARS-CoV-2 in a Married Couple: A Case Report
-
HTLV-I p30 inhibits multiple S phase entry checkpoints, decreases cyclin E-CDK2 interactions and delays cell cycle progression
-
Small molecule inhibitors against PD-1/PD-L1 immune checkpoints and current methodologies for their development: a review